Spring Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.7M Buy
42,915
+438
+1% +$38.6K 1.78% 22
2026
Q2
$3.32M Buy
42,477
+2,331
+6% +$188K 1.62% 24
2026
Q1
$3.48M Sell
40,146
-1,573
-4% -$151K 1.76% 23
2025
Q4
$4.01M Buy
41,719
+586
+1% +$56.9K 2.03% 21
2025
Q3
$3.92M Buy
41,133
+2,433
+6% +$224K 1.92% 21
2025
Q2
$3.37M Sell
38,700
-333
-0.9% -$28.2K 1.78% 22
2025
Q1
$3.51M Buy
+39,033
New +$3.49M 1.91% 23
2022
Q3
– Sell
-36,325
Closed -$3.26M – 31
2022
Q2
$3.26M Buy
+36,325
New +$3.68M 2.89% 19
2022
Q1
– Sell
-30,026
Closed -$3.11M – 32
2021
Q4
$3.11M Buy
+30,026
New +$3.48M 2.47% 20

Other funds holding MDT

Spring Capital Management's MDT Position: Q3 2026 in Review

Spring Capital Management increased its Medtronic (MDT) stake by 1% in Q3 2026, buying an estimated $38.6K and bringing the position to 42,915 shares worth $3.7M. The position accounts for 1.78% of the portfolio, ranked #22.

Spring Capital Management first reported a position in MDT in Q4 2021 and has held it in 9 quarters since. The position peaked at $4.01M in Q4 2025. 644 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Spring Capital Management held 42,915 shares of Medtronic worth $3.7M as of Q3 2026.
  • Spring Capital Management bought 438 Medtronic shares in Q3 2026, an estimated $38.6K.
  • Medtronic made up 1.78% of Spring Capital Management's portfolio in Q3 2026, its #22 holding.
  • Spring Capital Management first reported a position in Medtronic in Q4 2021 and has held it in 9 quarters since.
  • Spring Capital Management's Medtronic position peaked at $4.01M in Q4 2025.
  • 644 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Spring Capital Management's 13F filing for Q3 2026, filed 9 Oct 2026.